AIDOT developed Cerviray A.I., an artificial intelligence-based diagnostic solution that combines traditional cervical enlargement photography and artificial intelligence to make cervical cancer screening faster and more accurate -- in fact, we’ve achieved 90% accuracy in a certified test report in 2019. This is in contrast to the 50% false-negative rate common for cervical cancer tests. AIDOT's solution is handheld and mobile phone or tablet-based. It enables all healthcare professionals to detect cervical dysplasia and cancer with just one click within ten seconds for AI analysis, while cytology tests require over a week's time. Cerviray AI is the world's first solution combining'artificial intelligence' and'remote medicine' in the field of cervical cancer diagnosis. Cerviray AI is faster, simpler, and cheaper by using the Colposcopy method of magnifying the cervix, not the general cytology method (Cytology). A leader in the medical ICT field, Idot is a pioneer in next-generation medical diagnosis technology.